FOLH1 and neoplasm: We further hypothesized that the expression of FOLH1 in tumor relative to normal tissue may differentiate between tumor histologies that have historically responded to PSMA radioligand therapies or demonstrated significant uptake on diagnostic PSMA PET imaging versus those that did not.